✦ LIBER ✦

4521 POSTER Sequential high dose chemotherapy with paclitaxel and etoposide, carboplatin, melphalan and autologous stem cell support in patients with germ cell tumors; a phase II study

✍ Scribed by Koumakis, G.; Tryfonopoulos, D.; Vassilomanolakis, M.; Barbounis, V.; Res, E.; Demiri, S.; Tsoukalas, N.; Droufakou, S.; Filis, I.; Efremidis, A.

Book ID: 121947301
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 58 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71152-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High Dose Carboplatin, Etoposide, Melpha

High Dose Carboplatin, Etoposide, Melphalan and Autologous Hematopoietic Stem Cell Rescue with for the Treatment of Relapsed Pediatric Germ Cell Tumors

✍ N.C. Villela; R.V. Gouveia; C.R.D.P. Macedo; V.G. Zecchin; V.C. Ginani; J.F. Mar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Long-term results of first-line sequenti

Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor

✍ Tsuneharu Miki; Yoichi Mizutani; Hideyuki Akaza; Seiichiro Ozono; Taiji Tsukamot 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Phase I/II Study of Paclitaxel Plus Ifos

Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors

✍ Feldman, Darren R.; Glezerman, Ilya; Patil, Sujata; Van Alstine, Lindsay; Bajori 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 141 KB

High-dose chemotherapy with carboplatin,

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study

✍ Kleiner, S; Kirsch, A; Schwaner, I; Kingreen, D; Schwella, N; Huhn, D; Siegert, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Phase I study of high-dose thiotepa with

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors

✍ Pession, Andrea; Prete, Arcangelo; Locatelli, Franco; Bella, Santiago; Melchiond 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Background. The aim of this phase I study was to define the maximum tolerated dose (MTD) of thiotepa (TT), administered with busulfan (BU) 480 mg/m 2 and etoposide 2,400 mg/m 2 , followed by autologous bone marrow transplantation (ABMT) or peripheral blood stem cell transplantation (APBSCT) support

A phase I–II study of high-dose melphala

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

✍ Weaver, C H; Greco, F A; Hainsworth, J D; Zhen, B; Baldwin, P; Wittlin, F; Lewis 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB